Affordability Check
How to afford BOMYNTRA
Generic name: Denosumab
Pick how you're covered. We'll show you the cheapest legitimate way to get BOMYNTRA — your insurance copay, manufacturer savings, charity grants, or cash price. It takes 30 seconds and we never ask for your personal information.
Pick an option above to see your specific path.
Different insurance means different laws and different savings. For example, Medicare patients cannot use manufacturer copay cards (federal law) — but the manufacturer almost always has a Patient Assistance Program that gives the drug free.
About BOMYNTRA and its cost
What is this medication? Amvuttra is a prescription medication used for the treatment of polyneuropathy associated with hereditary transthyretin-mediated amyloidosis in adults. This condition is a rare genetic disorder characterized by the buildup of abnormal protein deposits in the nerves, which can lead to symptoms like pain, weakness, and a loss of sensation in the hands and feet. The medication is specifically intended to help manage these nerve-related symptoms and improve the physical capabilities of patients affected by the disease. This medication works by utilizing RNA interference technology to reduce the levels of transthyretin protein produced by the liver. By decreasing the overall amount of this protein in the body, the treatment helps to prevent the further accumulation of amyloid deposits that cause nerve damage. It is generally administered as a subcutaneous injection by a healthcare professional once every three months, providing a regular schedule for therapeutic intervention against the progression of the illness.
BOMYNTRA is made by Alnylam Pharmaceuticals. Like most brand-name drugs, it's priced at a high list price — but patients rarely pay that list price. The options above are the real paths most people use to get it affordably.
Common questions
What's the cheapest way to afford BOMYNTRA?
It depends on your insurance. On Medicare, apply for the manufacturer's Patient Assistance Program (PAP) — it gives the drug free if you meet income requirements. With private insurance, the manufacturer copay card usually drops your copay to $0-$25. Uninsured patients should compare the PAP with Cost Plus Drugs cash price.
Can I use a copay card with Medicare for BOMYNTRA?
No — federal law (the Anti-Kickback Statute) prohibits manufacturer copay cards on Medicare, Medicaid, TriCare, and VA prescriptions. But Alnylam Pharmaceuticals has a separate Patient Assistance Program for Medicare beneficiaries. Check the options above.
Does my Medicare Part D plan cover BOMYNTRA?
Part D coverage varies by plan. We query the CMS Prescription Drug Plan file to show you what percentage of plans cover it and at what tier. For your exact copay, pick "Medicare" above and check your plan's Summary of Benefits, or log in to Medicare.gov.
How long does a Patient Assistance Program take?
Most PAPs take 2-6 weeks from application to first fill. Ask the manufacturer about a "bridge supply" — many will ship 30 days free while your application is being reviewed so you don't go without the drug.
What if I have a high-deductible plan?
For generics, Cost Plus Drugs cash price is often cheaper than your deductible-phase copay. For brand names, the manufacturer copay card almost always wins. A GoodRx coupon can be a last resort for uncovered drugs, but it doesn't count toward your deductible.
Are there charity grants for Ovarian Cancer?
Charities like HealthWell Foundation, PAN Foundation, Good Days, and the National Organization for Rare Disorders provide copay help for specific conditions. Funds often run out mid-year — apply early. We list the specific grants for your condition in the options above.
More about BOMYNTRA
Full BOMYNTRA drug page
FDA label, prior authorization rules, full indications list
More options for Ovarian Cancer
Drugs, grants, and assistance for this condition
Guide to Patient Assistance Programs
How PAPs work, who qualifies, typical wait times
If your insurance denied coverage
5-level appeal playbook — Medicare has a 60% win rate at Level 3